Company: SNWV
Filing Date: 2025-07-10
Form Type: DEF 14A
Source: 0001140361-25-025486
Chunk: 44

Company: SANUWAVE Health, Inc.
Filing Date: 2025-07-10
Form: DEF 14A
Chunk 44
---
 covered fiscal year that are outstanding and unvested at year-end                                                                                        |     |     — |     | 2,551,416 |     |  1,445,808 |
| +/- The difference between fair value of awards from the end of the prior fiscal year to the end of the covered year for awards granted in any prior fiscal year that are outstanding and unvested at year end   |     |     — |     |         — |     |          — |
| +/- Add the fair value as of the vesting date for awards granted and vesting during such fiscal year                                                                                                             |     |     — |     |    20,002 |     |          — |
| +/- The difference in fair value at the end of the prior fiscal year to the vesting date for awards granted in any prior fiscal year for which all applicable vesting conditions were satisfied during such year |     |     — |     |         — |     |          — |
| Subtract fair value at end of prior year for awards granted in any prior fiscal year that fail to meet the applicable vesting conditions during such year                                                        |     |     — |     |         — |     |          — |
| Compensation Actually Paid (as calculated)                                                                                                                                                                       |     |     — |     | 2,571,422 |     |  1,709,408 |

| (3) | Total shareholder return is calculated based on a fixed investment of one hundred dollars measured from the market close on December 31, 2021 (the last trading day of fiscal 2021) through and including the end of each fiscal year reported in the table. |

29

TABLE OF CONTENTS Relationship between Pay and Performance The charts shown below present a graphical comparison of CAP to our PEOs and the average CAP to our Other NEOs set forth in the Pay Versus Performance Table above, as compared against our total shareholder return (“TSR”) and net income. CAP versus Company TSR Total shareholder return in the above chart reflects the cumulative return of $100 as if invested on December 31, 2021, including reinvestment of any dividends. CAP versus Net Income (Loss) 30

TABLE OF CONTENTS

DIRECTOR COMPENSATION TABLE FOR FISCAL YEAR 2024 Beginning October 2024, the director compensation plan changed from a base retainer of cash to quarterly grants of stock options with an aggregate grant date fair value equal to $20,000. We also provide an additional quarterly grant of stock options with